Unmanned Vehicles Technology Innovative Experimentation Act Article 7
The competent authority shall review the following items in the application for innovative experimentation:1.That it has innovativeness;2.Confirm that, within its scope of experimentation, it is not possible to obtain the permission or approval of the competent authority in charge of the end enterprises concerned in accordance with current laws and regulations, and that, in order to proceed with the innovative experimentation, certain applicable laws, regulations, orders or administrative rules from which it should be exempt;3.That it has the feasibility of being a public open field experiment, and includes data of relevant experience and analysis from the simulation or closed field testing;4.That it can effectively improve the efficiency of transportation services or systems, and improve safety, or reduce operating and usage costs;5.That it includes measures to maintain smooth traffic flow and ensure traffic safety;6.That its potential risks have been assessed, and that relevant response measures and other safety or risk control measures, relating to the innovative experimentation program, have been established;7.That it has established protective measures for experiment participants and experiment stakeholders, and has advanced preparations in place for appropriate compensation, as required;8.Any other matters, pursuant to the decision of the review meeting, that should be explained by the applicant.
中文原文 無人載具科技創新實驗條例第7條
主管機關對於創新實驗之申請，應審查下列項目：
一、具有創新性。
二、確認屬於依現行法規無法取得目的事業主管機關許可或核准之範疇，及為進行創新實驗而應排除適用之法律、法規命令或行政規則。
三、具有於開放性場域實驗之可行性，並已提出曾於模擬或封閉性場域測試之相關經驗及數據分析資料。
四、可有效提升交通運輸服務或系統之效率、提升安全或降低經營及使用成本。
五、已提出維持交通順暢及確保交通安全之因應措施。
六、已評估潛在風險並定有相關因應措施，及其他與創新實驗計畫相關之安全或風險控管措施。
七、建置參與實驗者及實驗利害關係人之保護措施，並預為準備適當補償。
八、其他經審查會議決議應由申請人提出說明之事項。
一、具有創新性。
二、確認屬於依現行法規無法取得目的事業主管機關許可或核准之範疇，及為進行創新實驗而應排除適用之法律、法規命令或行政規則。
三、具有於開放性場域實驗之可行性，並已提出曾於模擬或封閉性場域測試之相關經驗及數據分析資料。
四、可有效提升交通運輸服務或系統之效率、提升安全或降低經營及使用成本。
五、已提出維持交通順暢及確保交通安全之因應措施。
六、已評估潛在風險並定有相關因應措施，及其他與創新實驗計畫相關之安全或風險控管措施。
七、建置參與實驗者及實驗利害關係人之保護措施，並預為準備適當補償。
八、其他經審查會議決議應由申請人提出說明之事項。